Compare Aptiv PLC (APTV) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aptiv PLC vs GSK plc — how do they compare? Aptiv PLC trades at $50 (market cap $10.30B), while GSK plc trades at $50.58 (market cap $102.60B). The key difference: GSK plc is far larger — about 10× Aptiv PLC's market cap, and GSK plc pays a 3.57% dividend while Aptiv PLC pays none. Which is the better fit depends on your goals.
| APTV | GSK | |
|---|---|---|
Market Cap | $10.30B | $102.60B |
Sector | Consumer Cyclical | Health |
52-Week High | $76.82 | $61.18 |
52-Week Low | $46.30 | $38.22 |
Enterprise Value | $15.23B | $123.04B |
Dividend Yield | — | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aptiv PLC
Aptiv's signal and power solutions segment supplies components and systems that make up a vehicle's electrical system backbone, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The advanced safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, advanced driver-assist technologies, and displays, as well as the development of software for these systems. Aptiv's largest customer is General Motors at roughly 12% of 2021 revenue, including sales to GM's Shanghai joint venture, followed by Stellantis at 11%, and Volkswagen at 9%. North America and Europe represented approximately 38% and 33% of total 2019 revenue, respectively.
Read more on APTV →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
